BIOLOGIC RESPONSE-MODIFYING AGENTS - WHAT IS AN APPROPRIATE PHASE-I-II STRATEGY

被引：0
|
作者：
CARTER, SK
机构：
[1] STANFORD UNIV,STANFORD,CA 94305
[2] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143
来源：
CANCER IMMUNOLOGY IMMUNOTHERAPY | 1980年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：207 / 210
页数：4
相关论文
共 50 条
  • [11] The ethics of phase I trials of biologic agents
    Stephen B Hanauer
    Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5 : 533 - 533
  • [12] PHASE-I-II DIAZIQUONE CHEMOTHERAPY IN BRAIN-TUMORS
    MADAJEWICZ, S
    SPAULDING, M
    BHIMANI, S
    AVELLANOSA, A
    DELOSSANTOS, R
    PERRY, A
    ZEIGLER, P
    KIRSHNER, J
    CANCER TREATMENT REPORTS, 1984, 68 (06): : 913 - 914
  • [13] HIGH-DOSE CISPLATIN - PHASE-I-II STUDY
    BRUNETTI, I
    MERLANO, M
    GRIMALDI, A
    BENEDETTI, G
    GARAVENTA, G
    MODENESI, M
    ROSSO, R
    TUMORI JOURNAL, 1986, 72 (06): : 691 - 691
  • [14] PHASE-I-II STUDY OF EPIRUBICIN IN MULTIPLE-MYELOMA
    CASE, DC
    ERVIN, TJ
    GAMS, R
    SONNEBORN, H
    PAUL, S
    OLDHAM, FB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 213 - 213
  • [15] PHASE-I-II STUDY OF EPIRUBICIN IN MULTIPLE-MYELOMA
    CASE, DC
    ERVIN, TJ
    GAMS, R
    SONNEBORN, HL
    PAUL, SD
    OLDHAM, FB
    CANCER RESEARCH, 1988, 48 (21) : 6246 - 6248
  • [16] Risks of serious infections in children treated with biologic response-modifying drugs Bacterial infection risk in children with juvenile idiopathic arthritis
    Abinun, Mario
    RHEUMATOLOGY, 2018, 57 (02) : 211 - 212
  • [17] PHASE-I-II TRIAL OF RECOMBINANT GAMMA-INTERFERON IN PATIENTS WITH RENAL-CELL CARCINOMA - IMMUNOLOGICAL AND BIOLOGIC EFFECTS
    RINEHART, JJ
    YOUNG, D
    LAFORGE, J
    COLBURN, D
    NEIDHART, J
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1987, 6 (03): : 302 - 312
  • [18] PHASE-I-II TRIAL OF ACIVICIN IN ADULT ACUTE-LEUKEMIA
    POWELL, BL
    CRAIG, JB
    CAPIZZI, RL
    RICHARDS, F
    INVESTIGATIONAL NEW DRUGS, 1988, 6 (01) : 41 - 44
  • [19] PHASE-I-II EVALUATION OF INTRAARTERIAL DIAZIQUONE FOR RECURRENT MALIGNANT ASTROCYTOMAS
    GREENBERG, HS
    ENSMINGER, WD
    LAYTON, PB
    GEBARSKI, S
    MEYER, M
    CHAFFEE, B
    BENDER, JF
    GRILLOLOPEZ, AJ
    CANCER TREATMENT REPORTS, 1986, 70 (03): : 353 - 357
  • [20] PHASE-I-II TRIAL OF COMBINATION THERAPY WITH ADRIAMYCIN (ADR) AND ICRF
    CHLEBOWSKI, R
    PUGH, R
    MCCRACKEN, J
    GLASS, A
    BATEMAN, JR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 199 - 199
12345